Disorders of Langerhans Cells

Histiocytoses - large group of heterogenous disorders with evolving clinical and molecular classifications
  • Age, comorbidities and systemic findings influence the clinical course
  • Pediatric workup ruling out aggressive paraneoplastic outcomes is paramount
  • Derived from a common CD34+ hematopoietic precursor
 
Histiocytes - descriptive term used in pathology for mononuclear phagocytes residing in tissues (histio=”tissue”, cyte “cell”). Includes tissue macrophage or a dendritic cell. Group of cells that represent the immune system for the skin, includes:
 
Langerhans Cell Histiocytosis derive from Langerhans Dendritic Cells; Non-LCH disorders derive from interstitial dermal cells; Granulomatous disorders derive from macrophages and monocyte derived dendritic cells
Langerhans Cell Histiocytosis derive from Langerhans Dendritic Cells; Non-LCH disorders derive from interstitial dermal cells; Granulomatous disorders derive from macrophages and monocyte derived dendritic cells
notion image
Life cycle of Langerhans cells. Note epidermotropism of immature Langerhans cell.
Life cycle of Langerhans cells. Note epidermotropism of immature Langerhans cell.
notion image
 
Histiocytosis classification - new
  • Langerhans Histiocytosis
  • Cutaneous & mucocutaneous Histiocytosis
  • Rosai-Dorfman
  • Malignant
  • Hemophagocytic lymphohistiocytosis & macrophage activation syndrome
https://doi.org/10.1182/blood-2016-01-690636
notion image